Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Berlin - Delayed Quote • EUR Vericel Corp (ATQP.BE) Follow Add holdings 33.80 +0.60 +(1.81%) As of 8:08:25 AM GMT+2. Market Open. Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for ATQP.BE 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: ATQP.BE View More All News Press Releases SEC Filings Travere Therapeutics (TVTX) Reports Q1 Loss, Tops Revenue Estimates Vericel Corp. (VCEL) Faces Challenges as Burn Care Revenue Wanes and MACI Growth Remains Uncertain Vericel to Report First-Quarter 2025 Financial Results on May 8, 2025 An Intrinsic Calculation For Vericel Corporation (NASDAQ:VCEL) Suggests It's 47% Undervalued Vericel to Present at Multiple Upcoming Investor Conferences Vericel Full Year 2024 Earnings: EPS Beats Expectations Vericel Corp (VCEL) Q4 2024 Earnings Call Highlights: Record Revenue and Strong Growth Trajectory Q4 2024 Vericel Corp Earnings Call Vericel Corporation (VCEL) Tops Q4 Earnings Estimates Vericel Reports Fourth Quarter and Full-Year 2024 Financial Results High Growth Tech Stocks To Watch In February 2025 Related Tickers VERA Vera Therapeutics, Inc. 25.31 +6.57% PTN Palatin Technologies, Inc. 0.2179 -0.05% BCRX BioCryst Pharmaceuticals, Inc. 8.93 +2.53% IOVA Iovance Biotherapeutics, Inc. 3.5000 +5.11%